AbCellera Biologics, Inc. (ABCL)
5.20
+0.06
(+1.17%)
USD |
NASDAQ |
May 22, 16:00
5.26
+0.06
(+1.15%)
Pre-Market: 20:00
AbCellera Biologics EPS Diluted (Quarterly) : -0.1424 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tempus AI, Inc. | -0.7101 |
| Standard BioTools, Inc. | -0.1165 |
| Cytek Biosciences, Inc. | -0.1466 |
| Agilent Technologies, Inc. | 1.074 |
| Inotiv, Inc. | -0.9369 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -43.16M |
| Revenue (Quarterly) | 8.315M |
| Total Expenses (Quarterly) | 51.48M |
| Enterprise Value | 1.198B |
| Gross Profit Margin (Quarterly) | -4.09% |
| Profit Margin (Quarterly) | -519.1% |
| Earnings Yield | -9.22% |
| Normalized Earnings Yield | -9.260 |